Myovant Sciences to Participate in the Evercore ISI 4th Annual HealthCONx Conference

BASEL, Switzerland, Nov. 23, 2021 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, will participate in the Evercore ISI 4th Annual HealthCONx Conference on November 30, 2021. David Marek, Chief Executive Officer of Myovant Sciences, Inc. will participate in a fireside chat at 11:45 a.m. Eastern Time.

Investors and the general public are invited to listen to the Evercore fireside chat, which will be accessible on the Events page under the Investors & Media section of the Myovant website at www.myovant.com.

About Myovant Sciences
Myovant Sciences aspires to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. Founded in 2016, Myovant has executed five successful Phase 3 clinical trials across oncology and women’s health leading to two regulatory approvals by the U.S. Food and Drug Administration for men with advanced prostate cancer and women with heavy menstrual bleeding associated with uterine fibroids, respectively, as well as a European Commission approval for women with symptomatic uterine fibroids. Additionally, Myovant has two regulatory submissions under review, a Marketing Authorization Application in advanced prostate cancer and a supplemental New Drug Application in endometriosis-associated pain. Myovant is conducting a Phase 3 study to evaluate the prevention of pregnancy in women with uterine fibroids or endometriosis. Myovant is also developing MVT-602, an investigational oligopeptide kisspeptin-1 receptor agonist, which has completed a Phase 2a study for female infertility as part of assisted reproduction. Sumitovant Biopharma, Ltd., a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., is Myovant’s majority shareholder. For more information, please visit www.myovant.com. Follow @Myovant on Twitter and LinkedIn.

Investor Contact:
Ryan Crowe
Vice President, Investor Relations
Myovant Sciences, Inc.
+1 (650) 781-9106
investors@myovant.com

Story continues

Media Contact:
Albert Liao
Director, Corporate Communications
Myovant Sciences, Inc.
+1 (650) 410-3055
media@myovant.com

Baby News

Related Posts

The History Of Fertility Treatments Like IUI And IVF Is Disturbing

Comments Off on The History Of Fertility Treatments Like IUI And IVF Is Disturbing

Family Fertility Fund of Sask. holds walk to raise awareness about infertility

Comments Off on Family Fertility Fund of Sask. holds walk to raise awareness about infertility

Mistletoe isn’t romantic when it’s in your trees — it’s a parasite

Comments Off on Mistletoe isn’t romantic when it’s in your trees — it’s a parasite

Marine organism compounds may have potential to help human fertility

Comments Off on Marine organism compounds may have potential to help human fertility

Who Will Replace Nunes? GOP Holds Congressional Forum Tuesday – GV Wire

Comments Off on Who Will Replace Nunes? GOP Holds Congressional Forum Tuesday – GV Wire

Childhood cancer patients left infertile by treatment could soon be able to father children

Comments Off on Childhood cancer patients left infertile by treatment could soon be able to father children

Kourtney Kardashian Provides Update on Her IVF Journey on ‘The Kardashians’

Comments Off on Kourtney Kardashian Provides Update on Her IVF Journey on ‘The Kardashians’

Global IVF Devices and Consumables Market (2021 to 2030) – by Product, Technology Type, End-user and Region

Comments Off on Global IVF Devices and Consumables Market (2021 to 2030) – by Product, Technology Type, End-user and Region

Bonei Olam Chabad to Hold Second Evening of Awareness

Comments Off on Bonei Olam Chabad to Hold Second Evening of Awareness

Elon Musk and Shivon Zilis conceived twins through IVF: report

Comments Off on Elon Musk and Shivon Zilis conceived twins through IVF: report

What does the colour of your period says about being infertile? Doctors answer | Health

Comments Off on What does the colour of your period says about being infertile? Doctors answer | Health

BBC Woman’s Hour presenter Emma Barnett reveals she is expecting her second child

Comments Off on BBC Woman’s Hour presenter Emma Barnett reveals she is expecting her second child

Create Account



Log In Your Account